Agree. On science taking its time, one thing that baffles me is that in the US and the UK, HCQ trials are only starting, as we reach the tail of this pandemic. Would someone know what is the rationale for waiting so long?
They're not only starting now, they've been going since early February. This one just finished: https://www.nejm.org/doi/full/10.1056/NEJMoa2016638. It found no preventive effect. Other trials are looking at treatment effectiveness.
It’s really frustrating that the theorized mechanism of HCQ effectiveness as a prophylactic is its ability to transport zinc across cell walls (zinc interrupts the viral RNA replication), yet these trials don’t include zinc supplements.
